Pharmaceutical

NATCO Pharma Limited Q3FY23 Earnings

● Feb 22, 2023

A pharmaceutical firm with a strong focus on research and development, NATCO Pharma Ltd creates, produces, and markets sophisticated pharmaceuticals...

Pfizer Limited Q3FY23 Earnings Story

● Feb 16, 2023

Pfizer Ltd is primarily involved in marketing, exporting, manufacturing, and trading of pharmaceutical products. It produces goods through its in-house...

Panacea Biotec Q3FY23; 26% Fall in Revenue

● Feb 14, 2023

Panacea Biotec Limited’s revenue in Q3FY23 fell 26% to ₹ 11,520 lakhs. Consolidated Profit After Tax came at ₹ 1,937...

Lupin Ltd (LUPIN) Q3 FY23 Earnings Concall Transcript

● Feb 12, 2023

Lupin Ltd (NSE:LUPIN) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Vinita Gupta — Chief Executive Officer Ramesh Swaminathan — Executive Director,...

Lupin Limited Q3FY23; 47% Growth in Profits

● Feb 9, 2023

Lupin Limited’s revenue in Q3FY23 rose 13% to ₹ 1,97,66,301 lakhs. Consolidated Profit After Tax came at ₹ 8,34,871 lakhs...

Sun Pharmaceutical Q3FY23; 3% Growth in Profits

● Feb 8, 2023

Sun Pharmaceutical Industries Limited’s revenue in Q3FY23 rose 14% to ₹ 112,410 millions. Consolidated Profit After Tax came at ₹...

Aurobindo Pharma Q2FY23; 41% Fall in Profits

● Nov 14, 2022

Aurobindo Pharma Ltd.‘s revenue in Q2FY23 fell 3% to ₹ 5,739 crores. Consolidated Profit came at ₹ 409 crores showcasing...

Divi’s Laboratories Q2FY23; 19% Fall in Profits

● Nov 7, 2022

Divi’s Laboratories Ltd.‘s revenues in Q2FY23 fell 7% to ₹ 1,855 crores. Consolidated Profit came at ₹ 494 crores showcasing...

Torrent Pharmaceuticals Limited Q2FY23; Profits down by 1%

● Oct 21, 2022

Torrent Pharmaceuticals Ltd.‘s Revenues for Q2 FY23 has increased by 7% YoY to ₹ 2,291 crores. Net Profit fell by...

Apollo Hospitals Enterprise Limited Q1FY23; 35% fall in Profits

● Aug 12, 2022

Revenue for Q1 FY23 has increased by 1% YoY to ₹ 37,956 millions. Profits have fallen by 35% YoY to...